If approved, a type of group lawsuit called a multicounty litigation (MCL) will be created
This personalized journey ensures effective solutions for sustainable weight loss and overall well-being
Since ESSENCE was designed to evaluate semaglutide in participants with underlying liver disease, hepatic function tests were measured every 12 weeks, and criteria were established for discontinuation in participants with an increase in pre-specified changes in ALT, AST, total bilirubin, or INR (Supplemental Table S1, Among the 538 participants receiving semaglutide, none stopped it because of elevated ALT or AST
Sharing it can cause serious infections
Never again
Additionally, these medications may alter food preferences, with many patients reporting reduced cravings for high-fat and high-sugar foods